Amphenol Corporation income statement & cash flow
In the fiscal year ended Dec 31, 2025, Amphenol Corporation reported net income of $4.27B on revenue of $23.09B. Operating cash flow was $5.37B and capital expenditures were $996.60M, leaving $4.38B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.29B | $7.01B | $8.20B | $8.23B | $8.60B | $10.88B | $12.62B | $12.55B | $15.22B | $23.09B |
| Gross profit | $2.04B | $2.31B | $2.65B | $2.62B | $2.66B | $3.40B | $4.03B | $4.08B | $5.14B | $8.52B |
| Operating income | $1.21B | $1.43B | $1.69B | $1.62B | $1.64B | $2.11B | $2.59B | $2.56B | $3.16B | $5.87B |
| Net income | $822.90M | $650.50M | $1.21B | $1.16B | $1.20B | $1.59B | $1.90B | $1.93B | $2.42B | $4.27B |
| Diluted EPS | $2.61 | $2.06 | $3.85 | $1.88 | $1.96 | $2.54 | $1.53 | $1.55 | $1.92 | $3.34 |
| Operating cash flow | $1.08B | $1.14B | $1.11B | $1.50B | $1.59B | $1.54B | $2.17B | $2.53B | $2.81B | $5.37B |
| Capital expenditures | $190.80M | $226.60M | $310.60M | $295.00M | $276.80M | $360.40M | $383.80M | $372.80M | $665.40M | $996.60M |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | 36.9% | 25.4% | 18.5% |
| Dec 2024 | 33.8% | 20.7% | 15.9% |
| Dec 2023 | 32.5% | 20.4% | 15.4% |
| Dec 2022 | 31.9% | 20.5% | 15.1% |
| Dec 2021 | 31.3% | 19.4% | 14.6% |
Source: SEC EDGAR XBRL company facts for CIK 820313 (raw data). Most recent filing in this dataset: 10-Q filed Oct 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.